Target intelligence / Profile preview

LRRC2 antisense RNA 1 (LRRC2-AS1)

Target: LRRC2-AS1
Molecular classification: Other (long non-coding RNA, lncRNA)

Overview

LRRC2 antisense RNA 1 (LRRC2-AS1) is a long non-coding RNA (lncRNA) gene that does not encode a protein but is affiliated with gene regulation at the transcript level[1][6]. It is located on chromosome 3 adjacent to the protein-coding gene LRRC2, which is involved in tumor suppression and cardiovascular biology[3][5]. Aliases such as LUZP3, LUZPP1, and LUZZ3P reflect previous gene annotations and related pseudogenes[1]. LRRC2-AS1 has been statistically associated with diseases including glioma susceptibility and schizophrenia in genetic studies[1]. There is currently no evidence that LRRC2-AS1 is directly targeted by drugs, nor is it classified as a therapeutic target. The biological function of LRRC2-AS1 remains unclear, though it may participate in regulatory networks relevant to cell biology and disease[1][6].

Other names: LRRC2 antisense RNA 1LRRC2-AS1LUZP3LUZP3PLUZPP1NONHSAT089447.2

Mechanism of action

no drugs are known to target LRRC2-AS1 directly

Biological functions

Other (potential regulation of gene expression in neurologic and cancer contexts, but specific functions remain undefined)

Disease associations

Cancer (association with glioma susceptibility)Schizophrenia (reported genetic associations)Other (possible involvement with disease phenotypes in expression datasets, but mechanisms are unclear)

Beyond the preview

Go deeper on LRRC2 antisense RNA 1 (LRRC2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LRRC2 antisense RNA 1 (LRRC2-AS1).

Explore the full profile